Who owns CASI PHARMACEUTICALS INC?
- Ticker: CASIF
- CUSIP Number: g1933s101
Tip: Access positions for across all investors
Analyze quarterly positions in Casi Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Casi Pharmaceuticals stock
Who bought or sold CASI PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Renaissance Technologies | 43k | $37k | -2% | Dec 2025 |
|
| Simplex Trading | 133.00 | $112.996800 | -8% | Dec 2025 |
|
Who sold out of Casi Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| VR Adviser | Dec 2025 | 987k | $839k |
| Woodline Partners | Dec 2025 | 133k | $113k |
| Two Sigma Investments | Dec 2025 | 24k | $20k |
| Geode Capital Management | Dec 2025 | 19k | $16k |
| Citadel Advisors | Dec 2025 | 14k | $12k |
| Royal Bank of Canada | Sep 2025 | 10k | $0 |
| UBS Group | Dec 2025 | 659.00 | $560.018200 |
| Wells Fargo & Company | Dec 2025 | 505.00 | $428.997500 |
| Morgan Stanley | Dec 2025 | 367.00 | $310.555400 |
| Bnp Paribas Arbitrage, Snc | Dec 2025 | 134.00 | $113.993800 |